Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Detalles Bibliográficos
Autores principales: Terpos, Evangelos, Trougakos, Ioannis P., Gavriatopoulou, Maria, Papassotiriou, Ioannis, Sklirou, Aimilia D., Ntanasis-Stathopoulos, Ioannis, Papanagnou, Eleni-Dimitra, Fotiou, Despina, Kastritis, Efstathios, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061093/
https://www.ncbi.nlm.nih.gov/pubmed/33861315
http://dx.doi.org/10.1182/blood.2021011904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061093/
https://www.ncbi.nlm.nih.gov/pubmed/33861315
http://dx.doi.org/10.1182/blood.2021011904

Ejemplares similares